Page last updated: 2024-11-05

trimethoprim and Leukocytosis

trimethoprim has been researched along with Leukocytosis in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Leukocytosis: A transient increase in the number of leukocytes in a body fluid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shalit, M1
Levy, M1
McGeady, SJ1
Murphey, SA1

Other Studies

2 other studies available for trimethoprim and Leukocytosis

ArticleYear
Cotrimoxazole reaction simulating sepsis.
    The Journal of infection, 1984, Volume: 9, Issue:3

    Topics: Diagnosis, Differential; Drug Combinations; Female; Fever; Humans; Leukocytosis; Middle Aged; Sepsis

1984
Disseminated Mycobacterium kansasii infection.
    Clinical immunology and immunopathology, 1981, Volume: 20, Issue:1

    Topics: Cardiomegaly; Child, Preschool; Disseminated Intravascular Coagulation; Heart Failure; Humans; Immun

1981